Globe Biotech gets BMRC nod for human trials 
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Tuesday
February 07, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
TUESDAY, FEBRUARY 07, 2023
Globe Biotech gets BMRC nod for human trials 

Covid-19 in Bangladesh

TBS Report
23 November, 2021, 05:50 pm
Last modified: 23 November, 2021, 06:31 pm

Related News

  • UNFPA and BRAC host knowledge dissemination event on Covid-19
  • Decoding Monetary Policy Statement 2023: Was there any better alternative?
  • Manpower export to Malaysia to be made easier, faster: Minister
  • The supply chain crisis opens door to resilience
  • Preparing for the future of AI in the job market: How Bangladesh can thrive in a tech-driven world

Globe Biotech gets BMRC nod for human trials 

TBS Report
23 November, 2021, 05:50 pm
Last modified: 23 November, 2021, 06:31 pm
Globe Biotech gets BMRC nod for human trials 

Local pharmaceutical company Globe Biotech Ltd has received Bangladesh Medical Research Council (BMRC) approval to begin human trials of its single-dose Covid-19 vaccine "Bangavax."

"The BMRC has given us ethical permission to conduct human trials of Bangavax," confirmed Globe Biotech Senior Manager (quality and regulation) Dr Mohammad Mohiuddin to The Business Standard on Tuesday night.

"However, to start the trials we need permission from the Directorate General of Drug Administration (DGDA)."

Meanwhile, when contacted, DGDA Deputy Director Md Salahuddin, said, "We are yet to receive any official letter from the BMRC. It may take a couple of days to reach us.

"A decision in this regard will be taken following a review of the approval."

Globe, on 1 November, submitted a report on the results of the trial on monkeys to BMRC as per guidelines.

On 22 June, BMRC sent a letter to Globe Biotech asking it to conduct a trial on monkeys or chimpanzees before a clinical trial.

On 28 December, 2020, the vaccine developer got approval from the DGDA to produce the coronavirus jab to carry out clinical trials.

The results of animal trials were published on the Bio-Archive on 29 September the same year. 

In the same month, Globe also announced plans to launch human trials after completing Phase-II animal trials.

The company on 5 October claimed it had "very promising results" in the vaccine trials on rabbits and mice. 

Researchers had initially named it Bancovid but later renamed it as Bangavax. 

That month, the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) announced that it would hold a human trial of the locally produced vaccine and signed an MoU with Globe Biotech on 14 October to conduct the phase-I trial.

But Globe, on 1 December, cancelled its agreement with the icddr,b, alleging that the latter was not showing enough interest in conducting the trials of the vaccine candidate.

Earlier on 2 July last year, Globe declared it had developed a Covid-19 vaccine.

Top News / Health

Bangladesh / COVID-19 / Bangavax Trials / Coronavirus Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • A man stands in front of collapsed buildings following an earthquake in Kahramanmaras, Turkey February 6, 2023. Ihlas News Agency (IHA) via REUTERS ATTENTION EDITORS - THIS PICTURE WAS PROVIDED BY A THIRD PARTY. NO RESALES. NO ARCHIVES. TURKEY OUT. NO COMMERCIAL OR EDITORIAL SALES IN TURKEY.
    Deaths exceed 2,600 as catastrophic quakes ravage Turkey, Syria
  • 30% cos see double-digit growth even in hard times
    30% cos see double-digit growth even in hard times
  • Govt borrowing from commercial banks surges
    Govt borrowing from commercial banks surges

MOST VIEWED

  • Incepta Pharma abandons Covid vaccine plan
    Incepta Pharma abandons Covid vaccine plan
  • Test tube labelled "Covid-19 Omicron variant test positive" is seen in this illustration picture taken 15 January, 2022. PHOTO: REUTERS/Dado Ruvic/Illustration
    Tighter screening at ports urged as new Covid sub-variant BF.7 detected
  • Test tube labelled "Covid-19 Omicron variant test positive" is seen in this illustration picture taken 15 January, 2022. PHOTO: REUTERS/Dado Ruvic/Illustration
    First case of new Covid sub-variant Omicron BF.7 detected in Bangladesh: IEDCR
  • Illustration: Collected
    Genome sequencing reports of Chinese nationals infected with Covid by Sunday: IEDCR
  • Computer image of a betacoronavirus which is the type of virus linked to Covid-19
    4 Chinese nationals detected with Covid at Dhaka airport
  • Omicron BF7: Land ports still left unguarded
    Omicron BF7: Land ports still left unguarded

Related News

  • UNFPA and BRAC host knowledge dissemination event on Covid-19
  • Decoding Monetary Policy Statement 2023: Was there any better alternative?
  • Manpower export to Malaysia to be made easier, faster: Minister
  • The supply chain crisis opens door to resilience
  • Preparing for the future of AI in the job market: How Bangladesh can thrive in a tech-driven world

Features

Photo: Collected

Get your partner a lovely present this Valentine's Day

15h | Brands
Pottery Wheel Craft Kit: A creative outlet for little hands

Pottery Wheel Craft Kit: A creative outlet for little hands

15h | Brands
Say it with Colours

Say it with Colours

1d | Mode
Photo: Courtesy

From 'Made in Bangladesh' to 'Designed in Bangladesh'

1d | Panorama

More Videos from TBS

Who will survive? Adani or Hindenburg?

Who will survive? Adani or Hindenburg?

6h | TBS Stories
James Gunn’s 8-10-year plan for the DC Universe

James Gunn’s 8-10-year plan for the DC Universe

6h | TBS Entertainment
LC issues lead to severe shortage of surgical equipment

LC issues lead to severe shortage of surgical equipment

9h | TBS Insight
Stage plays are going on in the digital age

Stage plays are going on in the digital age

14h | TBS Stories

Most Read

1
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

2
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

3
Belal Ahmed new acting chairman of SIBL
Banking

Belal Ahmed new acting chairman of SIBL

4
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

5
Photo: Collected
Startups

ShopUp secures $30m debt financing to boost expansion, supply chain

6
Photo: Courtesy
Panorama

From 'Made in Bangladesh' to 'Designed in Bangladesh'

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]